Medicines Discovery Catapult (Cheshire, UK), Retrogenix (High Peak, UK) and Peak Proteins (Cheshire, UK) have entered a new three-way collaboration to identify potential target receptors for COVID-19 therapies.
Results of a new multi-institutional study led by researchers at University of Illinois at Urbana-Champaign (IL, USA) indicate that a portable testing device clipped to a smartphone could detect pathogens in biological samples in minutes.
A real-time RT-PCR test for SARS-CoV-2 – the virus responsible for COVID-19 – developed by Seegene (Seoul, South Korea) is one of the latest assays to be granted emergency use authorization by the US FDA.
Genedrive (Manchester, UK) and Cytiva (formerly GE Healthcare; IL, USA) have entered an international collaboration to develop a one step assay to detect SARS-CoV-2 for use on lab-based PCR instruments.
Researchers from institutions across Korea have developed a rapid antibody test to detect SARS-CoV-2 based on a field-effect transistor. The test can distinguish healthy individuals’ nasopharyngeal swab samples from COVID-19 patients’ swabs with no sample preparation required.
Scientists from The University of Zurich (Switzerland) and Institute of Environmental Engineering (Zurich, Switzerland) have developed a diagnostic assay to detect RNA sequences from SARS-CoV-2, the virus responsible for COVID-19.
Researchers from the University of Pennsylvania School of Medicine (PA, USA) demonstrated in a multidisciplinary blinded study that a liquid biopsy was more accurate for detecting the early stages of pancreatic ductal adenocarcinoma other biomarkers alone.
Rutgers University (NJ, USA) and collaborators have become the first to receive emergency use authorization from the US FDA for a COVID-19 diagnostic test that utilizes saliva as the main test biomaterial.
UK-based life sciences group Avacta (Wetherby, UK) have entered a new international partnership with Cytiva (MA, USA). The collaboration will work to develop and manufacture a rapid COVID-19 test to screen and diagnose large populations of individuals.